NY-ESO-1 antibody as a novel tumour marker of gastric cancer

被引：0
|
作者：
S Fujiwara
H Wada
J Kawada
R Kawabata
T Takahashi
J Fujita
T Hirao
K Shibata
Y Makari
S Iijima
H Nishikawa
A A Jungbluth
Y Nakamura
Y Kurokawa
M Yamasaki
H Miyata
K Nakajima
S Takiguchi
E Nakayama
M Mori
Y Doki
机构：
[1] Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Osaka University,Department of Experimental Immunology
[3] 2-2 Yamadaoka,undefined
[4] Suita-city (E-2),undefined
[5] Osaka 565-0871,undefined
[6] Japan,undefined
[7] Surgery,undefined
[8] Toyonaka Municipal Hospital,undefined
[9] Surgery,undefined
[10] Ikeda City Hospital,undefined
[11] Surgery,undefined
[12] Minoh City Hospital,undefined
[13] Immunology Frontier Research Center,undefined
[14] Osaka University,undefined
[15] 3-1 Yamadaoka,undefined
[16] Suita-city,undefined
[17] Osaka 565-0871,undefined
[18] Japan,undefined
[19] Ludwig Institute for Cancer Research,undefined
[20] New York Branch at Memorial Sloan-Kettering Cancer Center,undefined
[21] Faculty of Health and Welfare,undefined
[22] Kawasaki University of Medical Welfare,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
surgical treatment; detection marker; follow-up marker; recurrence; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1119 / 1125
页数：6
相关论文
共 50 条
  • [21] NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
    Thomas, Remy
    Al-Khadairi, Ghaneya
    Roelands, Jessica
    Hendrickx, Wouter
    Dermime, Said
    Bedognetti, Davide
    Decock, Julie
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [22] NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer
    Szender, J. Brian
    Papanicolau-Sengos, Antonios
    Eng, Kevin H.
    Miliotto, Anthony J.
    Lugade, Amit A.
    Gnjatic, Sacha
    Matsuzaki, Junko
    Morrison, Carl D.
    Odunsi, Kunle
    GYNECOLOGIC ONCOLOGY, 2017, 145 (03) : 420 - 425
  • [23] Application of serum NY-ESO-1 antibody assay for early SCLC diagnosis
    Yang, Jihua
    Jiao, Shunchang
    Kang, Jingbo
    Li, Rong
    Zhang, Guanzhong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14959 - 14964
  • [24] NY-ESO-1 immunotherapy for multiple myeloma
    Szmania, Susann
    Tricot, Guido
    van Rhee, Frits
    LEUKEMIA & LYMPHOMA, 2006, 47 (10) : 2037 - 2048
  • [25] Toward the Total Chemical Synthesis of the Cancer Protein NY-ESO-1
    Harris, Paul W. R.
    Brimble, Margaret A.
    BIOPOLYMERS, 2010, 94 (04) : 542 - 550
  • [26] Evidence of immunoediting in NY-ESO-1/ISCOMATRIX cancer vaccination recipients
    Chew, S
    Kanaan, C
    Browning, J
    MacGregor, D
    Davis, I
    Cebon, J
    Tait, BD
    TISSUE ANTIGENS, 2005, 66 (05): : 378 - 378
  • [27] NY-ESO-1 may be a potential target for lung cancer immunotherapy
    Lee, L
    Wang, RF
    Wang, XA
    Mixon, A
    Johnson, BE
    Rosenberg, SA
    Schrump, DS
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1999, 5 (01): : 20 - 25
  • [28] Expression of NY-ESO-1 cancer testis antigen in prostate cancer.
    Jain, Rohit K.
    Xu, Bo
    Mehta, Rutika Jitesh
    Pop, Elena
    Mohler, James
    Odunsi, Kunle
    Chatta, Gurkamal S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Serum NY-ESO-1 and p53 antibodies as useful tumor markers in gastric cancer
    Kawada, Junji
    Saito, Takuro
    Kurokawa, Yukinori
    Kawabata, Ryohei
    Takeno, Atsushi
    Takeoka, Tomohira
    Nose, Yohei
    Wada, Hisashi
    Eguchi, Hidetoshi
    Doki, Yuichiro
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024, 8 (02): : 243 - 250
  • [30] NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer
    Argun Akcakanat
    Tatsuo Kanda
    Yu Koyama
    Michitoshi Watanabe
    Eiji Kimura
    Yutaka Yoshida
    Shintarou Komukai
    Satoru Nakagawa
    Shoji Odani
    Hiroshi Fujii
    Katsuyoshi Hatakeyama
    Cancer Chemotherapy and Pharmacology, 2004, 54 : 95 - 100
12345